Abstract View

Author(s): Rachana Hallale 1*1, Laxmikant Marewad 22, Dr. Padmaja S. Giram 33, Mr. Mahesh B. Manke44, Dr. Shivakumar S. Ladde 55

Email(s): 1rachanahallale366@gmail.com, 2

Address:

    1 Dept. of Pharmacology, Channabaseshwar College of Pharmacy (Degree), Latur, Maharashtra, IN 2 Dept. of Pharmacology, Channabaseshwar College of Pharmacy (Degree), Latur, Maharashtra, IN 3 HOD of Dept. of Pharmacology, Channabaseshwar College of Pharmacy (Degree), Latur, Maharashtra, IN 4 Asst. Prof. Dept. of Pharmacology Channabaseshwar College of Pharmacy (Degree) Latur, Maharashtra, IN 5 HOD of Dept. of Pharmacy Practice, Channabaseshwar College of Pharmacy (Degree), Latur, Maharashtra, IN

Published In:   Volume - 3,      Issue - 6,     Year - 2024

DOI: Not Available

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
Two characteristics of the systemic autoimmune illness rheumatoid arthritis (RA) involves extra-articular involvement and inflammatory arthritis. It is a long-term inflammatory condition that mostly affects the synovial joints and is often triggered by a confluence of environmental factors, including tobacco use, and genetics. If therapy is not administered, it generally starts symmetrically in small peripheral joints and progresses to proximal joints. Joint degeneration is the end outcome of cartilage loss and bone erosion brought on by chronic joint inflammation. If symptoms haven't been present for more than six months, they are considered early RA, whereas symptoms that have been present for more than six months are considered established RA is a progressive disease that, if untreated, raises mortality and morbidity. This exercise describes the evaluation and treatment of rheumatoid arthritis in addition to evaluating the role of the interprofessional team in improving patient care for people with the illness.

Cite this article:
Rachana Hallale , Laxmikant Marewad , Dr. Padmaja S. Giram , Mr. Mahesh B. Manke , Dr. Shivakumar S. Ladde . Comprehensive Review of Rheumatoid Arthritis (RA): Pathophysiology, Clinical Outcomes, and Treatment Approaches. IJRPAS, 2024; 3(6): 131-146.


References not available.

Related Images:



Recent Images



Methyl Red in Materials Engineering: A Systematic Review of Physicochemical, Energetic and Technological Applications Using the PRISMA Methodology
Nature to Laboratory Translation of Indole Scaffolds: Integrating Natural Product Diversity, Sustainable Synthesis, and Evidence Guided Medicinal Chemistry
Antidiuretic Hormone Deficiency and Central Diabetes Insipidus (Arginine Vasopressin Deficiency): Pathophysiology, Etiology, and Contemporary Management Strategies
Mechanistic Evaluation of Acalypha hispida in Psoriasis Using Network Pharmacology and In-vivo Experimental Models
Formulation and Evaluation of Solubility enhanced Aripiprazole Oro Dispersible Film for the improved patient compliance
LipoEdge™ Liposomal Zinc by WBCIL: From Critical Quality Attributes to Bioavailability Validation and Formulation Applications
Network Pharmacology: A Systems Biology Approach to Drug Discovery and Disease Mechanisms
Artificial Intelligence in Pharmaceutical Formulation Development: From Trial-and-Error to Data-Driven Design
Evaluation of In-Vitro Anti-Diabetic Activity And   Antioxidant Activity In Ethanolic and Hydroalcoholic Extract of leaves of Gymnema Sylvestre
Molecular Docking Approaches in Antibacterial Drug Discovery: Computational Insights into Natural Compounds

Tags